Why is lung cancer common in non-smoking women in Hong Kong: From epidemiologic to molecular studies

Chinese Medical Journal

Volumn 110, Issue 6, 1997, Pages 420-424

  Kit, Lam Wah ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; FEMALE; GENETICS; HONG KONG; HUMAN; INDOOR AIR POLLUTION; LUNG TUMOR; MUTATION; ONCOGENE RAS; REVIEW; SEX DIFFERENCE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AIR POLLUTION, INDOOR; FEMALE; GENES, P53; GENES, RAS; HONG KONG; HUMANS; LUNG NEOPLASMS; MUTATION; SEX FACTORS;

EID: 0002472470     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hospital Authority. Statistical report 1994/95, Hong Kong. 1995: Table 1.15.
2. Department of Health. Lung cancer in Hong Kong. In: Public health report no. 1: coronary heart disease and lung cancer. Hong Kong Government, 1994: 33-50.
3. Lam KY, Fu KH, Wong MP, et al. Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology 1993; 25:103.
4. Lam WK. Bronchial carcinoma in Chinese women in Hong Kong. Proc Royal Coll Physicians (Edinburgh) 1985; 15:268.
5. Lam WK. Carcinoma of the lung in women of Chinese origin (editorial). JAMA SEA 1995; 11:5.
6. Office of Health and Environmental Assessment, Office of Research and Development. Respiratory health effects of passive smoking: lung cancer and other disorders. Washington DC: US Environmental Protection Agency, 1992.
7. Lam TH, Kung ITM, Wong CM, et al. Smoking, passive smoking and histological types in lung cancer in Hong Kong Chinese women. Br J Cancer 1987; 56:673.
8. Koo LC, Ho JHC, Saw D, et al. Measurements of passive smoking and estimates of lung cancer risk among non-smoking Chinese females. Int J Cancer 1987; 39:162.
9. Gao YT. Risk factors for lung cancer among non-smokers with emphasis on lifestyle factors. Lung Cancer 1996; 14 (Suppl 1): 39.
10. Wang TJ, Zhou BS, Shi JP. Lung cancer in non-smoking Chinese women: a case-control study. Lung Cancer 1996; 14 (Suppl 1): 93.
11. Lei YX, Cai WC, Chen YZ, et al. Some lifestyle factors in human lung cancer: a case-control study of 792 lung cancer cases. Lung cancer 1996; 14 (Suppl 1): 121.
12. Koo LC, Ho JHC. Diet as a confounder of the association between air pollution and female lung cancer: Hong Kong studies on exposures to environmental tobacco smoke, incense and cooking fumes as examples. Lung Cancer 1996; 14 (Suppl 1): 47.
13. Koo LC, Lee N, Ho JHC. Do cooking fuels pose a risk for lung cancer: a case-control study of women in Hong Kong. Ecol Dis 1984; 2:255.
14. Koo LC, Ho JHC. Mosquito coil smoke and respiratory health among Hong Kong Chinese: results of three epidemiological studies. Indoor Environ 1994; 3:304.
15. Blot WJ, Xu ZY, Boice JD, et al. Indoor radon and lung cancer in China. J Natl Cancer Inst 1990; 82:1025.
16. Mumford JL, He XZ, Chapman RS, et al. Lung cancer and indoor air pollution in Xuanwei, China. Science 1987; 235: 217.
17. Du YX, Cha Q, Chen XW, et al. An epidemiological study of risk factors for lung cancer in Guangzhou, China. Lung Cancer 1996; 14 (Suppl 1): 9.
18. Shields PG, Xu GX, Blot WJ, et al. Mutagens from heated Chinese and US cooking oils. J Natl Cancer Inst 1995; 87: 836.
19. Samet JM, Skipper BJ, Humble CG, et al. Lung cancer risk and vitamin A consumption in New Mexico. Am Rev Respir Dis 1985; 131:198.
20. Ziegler RG, Mason TJ, Stemhagen A, et al. Carotenoid intake, vegetables, and the risk of lung cancer among white men in New Jersey. Am J Epidemiol 1986; 123: 1080.
21. Fontham ETH, Pickle LW, Haenzel W, et al. Dietary vitamins A and C and lung cancer risk in Louisiana. Cancer 1988; 62: 2267.
22. Candelora EC, Stockwell HG, Armstrong AW, et al. Dietary intake and risk of lung cancer in women who never smoked. Nutr Cancer 1992; 17:263.
23. Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18:1.
24. Rylander R, Axelsson G, Andersson L, et al. Lung cancer, smoking and diet among Swedish men. Lung Cancer 1996; 14 (Suppl 1): 75.
25. Wynder EL, Herbert JR, Kabat GC. Association of dietary fat and lung cancer. J Natl Cancer Inst 1987; 79:631.
26. Alavanja MCR, Brownson RC, Benichou J. Estimating the effect of dietary fat on the risk of lung cancer in non-smoking women. Lung Cancer 1996; 14 (Suppl 1): 63.
27. Koo LC. Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked. Nutr Cancer 1988; 11:155.
28. Zheng W, Blot WJ, Liao ML, et al. Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer 1987; 56: 501.
29. Kung ITM, Lui IOL, Loke SL, et al. Pulmonary scar cancer: a pathologic reappraisal. Am J Surg Path 1985; 9:391.
30. Lam WK, Hawkins BR, Kung ITM, et al. No association between HLA antigens and adenocarcinoma of the lung in non-smoking Chinese women in Hong Kong. Br J Dis Chest 1986; 80: 370.
31. Slebos JC, Kibbelaar RE, Dalesio O, et al. Ki-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323: 561.
32. Lung ML, Wong M, Lam WK, et al. Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 1992; 70:760.
33. Soussi T, Legros Y, Lubin R, et al. Multifactorial analysis of P53 alteration in human cancer: a review. Int J Cancer 1994; 57:1.
34. Takagi Y, Koo LC, Osada H, et al. Distinct mutational spectrum of the P53 gene in lung cancers from Chinese women in Hong Kong. Cancer Res 1995; 55:5354.
35. Lung ML, Wong MP, Skaanild MT, et al. P53 mutations in non-small cell lung carcinomas in Hong Kong. Chest 1996; 109:718.
36. Pleasants LM, Hansen MF. Identification of a polymorphism in intron 2 of the P53 gene. Hum Genet 1994; 93:607.
37. Ge H, Lam WK , Lee J, et al. Detection and evaluation of P53 intron 2 polymorphism in lung carcinomas in Hong Kong. Int J Cancer (Pred Oncol) 1996; 69:120.
38. Tamai S, Sugimura H, Caporaso NE, et al. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer. Int J Cancer 1990; 46: 411.
39. Weston A, Caporaso NE, Perrin LS, et al. Relationship of H-ras- 1, L-myc, and P53 polymorphisms with lung cancer risk and prognosis. Environ Health Perspec 1992; 98:61.
40. Nazar-Stewart V, Motulsky AG, Eaton DL, et al. The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993; 53:2313.
41. London SJ, Daly AK, Cooper J, et al. Polymorphism of glutathione S-transferase Ml and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 1995; 87:1246.
42. Ge H, Lam WK, Lee J, et al. Analysis of L-myc and GST Ml genotypes in Chinese non-small cell lung carcinoma patients. Lung Cancer 1996; 15:355.
43. Fong KM, Zimmerman PV, Smith PJ. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small-cell lung cancer. Gen Chromos Cancer 1994; 10:183.
44. Weston A, Willey JC, Modali R, et al. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 1989; 86:5099.
45. Bepler G, Garcia-Blanco MA. Three tumour-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA 1994, 91:5513.
46. Jesudasan RA, Slovak ML, Sen S, et al. Rearrangement of chromosome band 11q13 in HeLa cells. Anticancer Res 1994; 14:1727.
47. Rasio D, Negrini M, Manenti G, et al. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res 1995; 55:3988.
48. Chan ASK, Lam WK, Wong MP, et al. Chromosomal 11 alterations in non-small cell lung carcinomas in Hong Kong. Lung Cancer 1996; 15:51.